PlainRecalls
FDA Drug Moderate Class II Terminated

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Reported: February 1, 2023 Initiated: January 13, 2023 #D-0175-2023

Product Description

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Reason for Recall

Short Fill

Details

Recalling Firm
Nephron Sc Inc
Units Affected
387,000 vials
Distribution
Nationwide within the United States including Puerto Rico. Guatamala
Location
West Columbia, SC

Frequently Asked Questions

What product was recalled?
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4. Recalled by Nephron Sc Inc. Units affected: 387,000 vials.
Why was this product recalled?
Short Fill
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2023. Severity: Moderate. Recall number: D-0175-2023.